Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial
Eli Lilly and Company
Myron S Cohen; Ajay Nirula; Mark J Mulligan; Richard M Novak; Mary Marovich; Catherine Yen; Alexander Stemer; Stockton M Mayer; David Wohl; Blair Brengle; Brian T Montague; Ian Frank; Russell J McCulloh; Carl J Fichtenbaum; Brad Lipson; Nashwa Gabra; Julio A Ramirez; Christine Thai; Wairimu Chege; Margarita M Gomez Lorenzo; Nirupama Sista; Jennifer Farrior; Meredith E Clement; Elizabeth R Brown; Kenneth L Custer; Jacob Van Naarden; Andrew C Adams; Andrew E Schade; Matan C Dabora; Jack Knorr; Karen L Price; Janelle Sabo; Jay L Tuttle; Paul Klekotka; Lei Shen; Daniel M Skovronsky; BLAZE-2 Investigators